Daiichi Sankyo Official Seeks VC, Biotech Ties For More M&As
This article was originally published in PharmAsia News
Daiichi Sankyo plans to build on its acquisition of Germany's U3 Pharma biotech two years ago by seeking more acquisitions or partnerships to develop cancer treatments
You may also be interested in...
Dutch foot-care specialists TheOTCLab launches what it claims to be the world's first fungal nail plaster.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% during COVID-19 emergency measures as the UK tries to increase supplies
Coronavirus Update: Neurimmune, Ethris, Fujifilm, Brii In New Bids Against COVID-19, Reata, Ionis Delay Studies
Neurimmune and Ethris partner on inhaled therapy. Reata, Ionis and others delay trials, Brii announces China antibody alliance, Fujifilm starts favipiravir trials. World's largest trial for health workers starts.